| Other Names | Elagolix, 834153-87-6, (R)-Elagolix, NBI-56418, UNII-5B2546MB5Z, 5B2546MB5Z, NBI56418, ABT-620, DTXSID40232348, 834153-87-6 (free acid), Orilissa, NBI 56418, compound 10b (PMID 19006286), compound 10b [PMID 19006286], (R)-4-((2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2, 6-dioxo-3, 6-dihydropyrimidin-1(2H)-yl)-1-phenylethyl)amino)butanoic acid, 4-(((1R)-2-(5-(2-Fluoro-3-methoxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-4-methyl-2, 6-dioxo-3, 6-dihydropyrimidin-1(2H)-yl)-1-phenylethyl)amino)butanoic acid, 4-[[(1R)-2-[5-(2-fluoranyl-3-methoxy-phenyl)-3-[[2-fluoranyl-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2, 6-bis(oxidanylidene)pyrimidin-1-yl]-1-phenyl-ethyl]amino]butanoic acid, 4-{[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-4-methyl-2, 6-dioxo-1, 2, 3, 6-tetrahydropyrimidin-1-yl]-1-phenylethyl]amino}butanoic acid, Butanoic acid, 4-(((1R)-2-(5-(2-fluoro-3-methoxyphenyl)-3-((2-fluoro-6-(trifluoromethyl)phenyl)methyl)-3, 6-dihydro-4-methyl-2, 6-dioxo-1(2H)-pyrimidinyl)-1-phenylethyl)amino)-, Elagolix [USAN], Elagolix [USAN:INN], 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2, 6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoic acid, elagolixum, Elagolix?, Elagolix (USAN/INN), ELAGOLIX [INN], ELAGOLIX [MI], ELAGOLIX [WHO-DD], GTPL8362, SCHEMBL1642523, CHEMBL1208155, DTXCID40154839, H01CC03, CHEBI:177453, HEAUOKZIVMZVQL-VWLOTQADSA-N, GLXC-10786, BCP08827, EX-A1765, AKOS040733086, CS-5329, DB11979, AC-30676, DA-52850, HY-14789, MS-30861, NS00072618, D09335, EN300-19807339, BRD-K55808645-001-01-4, Q21098999, 4-(((1R)-2-(5-(2-FLUORO-3-METHOXYPHENYL)-3-((2-FLUORO-6-(TRIFLUOROMETHYL)PHENYL)METHYL)- 4-METHYL-2, 6-DIOXO-3, 6-DIHYDROPYRIMIDIN-1(2H)-YL)-1-PHENYLETHYL)AMINO)BUTANOIC ACID, 4-[[(1R)-2-[5-(2-luoro-3-methoxyphenyl)-3-[[2-luoro-6-(triluoromethyl)phenyl]methyl]-4-methyl-2, 6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoic acid, BUTANOIC ACID, 4-(((1R)-2-(5-(2-FLUORO-3-METHOXYPHENYL)-3-((2-FLUORO-6-(TRIFLUOROMETHYL)PHENYL)METHYL)-3, 6-DIHYDRO-4-METHYL-2, 6-DIOXO-1(2H)-PYRIMIDINYL)-1- PHENYLETHYL)AMINO)-, Elagolix Butanoic acid, 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3, 6-dihydro-4-methyl-2, 6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]amino]- 4-[[(1R)-2-[5-(2-Fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl, F5O |
|---|---|
| IUPAC Name | 1-(4-methylpiperazin-1-yl)-3-(5-nitrofuran-2-yl)prop-2-en-1-one |
| CAS | 845827-14-7 |
| Molecular Weight | 631.6 |
| Molecular Formula | C32H30F5N3O5 |
| SMILES | CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F |






